Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/FRX stock hub

TSX/FRX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/FRXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
329.3M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/FRX
In the news

Latest news · TSX/FRX

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E78.1
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-65.8
P25 -121.5P50 -40.9P75 0.5
ROIC-16
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/FRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
177
Groups with data
11
Currency
USD
Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
35
Employees Change
3%
Employees Change Percent
10.34
Enterprise value
CAD 278.9M
Exchange
Toronto Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
CA31447P1009
Last refreshed
2026-05-10
Market cap
CAD 329.3M
Price
CAD 9.65
Price currency
CAD
Rev Per Employee
1,748,843.97x
Sector
Healthcare
Sic
2836
Symbol
tsx/FRX
Website
https://www.fennecpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-4.06%
EV Earnings
-20.89x
EV/Sales
4.56x
Forward P/E
78.11x
P/B ratio
6.77x
P/S ratio
5.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-14.07%
EBITDA Margin
-13.84%
Gross margin
91.57%
Gross Profit
CAD 56M
Gross Profit Growth
-7.84%
Gross Profit Growth Q
65.56%
Gross Profit Growth3 Y
204.42%
Gross Profit Growth5 Y
199.37%
Net Income
CAD -13.4M
Net Income Growth Years
0%
Pretax Margin
-21.58%
Profit Margin
-21.82%
Profit Per Employee
CAD -381,602
ROA
-6.8
Roa5y
-25.84
ROCE
-10.46
ROE
-65.82
ROIC
-16.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
12.17%
Cagr15y
12.63%
Cagr1y
12.87%
Cagr20y
-7.71%
Cagr3y
-4.21%
Cagr5y
5.74%
EPS Growth Years
0
Revenue Growth
-6.09x
Revenue Growth Q
73.84x
Revenue Growth Quarters
3x
Revenue Growth Years
0x
Revenue Growth3 Y
207.52x
Revenue Growth5 Y
204.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
CAD 0.77
Assets
CAD 96.7M
Cash
CAD 50.4M
Current Assets
CAD 91.7M
Current Liabilities
CAD 14.4M
Equity
CAD 48.6M
Interest Coverage
-2.93
Liabilities
CAD 48.1M
Long Term Assets
CAD 5.1M
Long Term Liabilities
CAD 33.7M
Net Cash
CAD 50.4M
Net Cash By Market Cap
CAD 15.32
Net Cash Growth
404.36%
Net Debt Equity
CAD -1.04
Tangible Book Value
CAD 48.6M
Tangible Book Value Per Share
CAD 1.42
WACC
9.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.37
Inventory Turnover
2.87
Net Working Capital
CAD 27.1M
Quick ratio
5.71
Working Capital
CAD 77.5M
Working Capital Turnover
CAD 1.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-4.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
215.36%
1Y total return
12.87%
200-day SMA
10.86
3Y total return
-12.11%
50-day SMA
9.97
50-day SMA vs 200-day SMA
50under200
5Y total return
32.19%
All Time High
391.5
All Time High Change
-97.54%
All Time High Date
2001-06-05
All Time Low
0.27
All Time Low Change
3,474.07%
All Time Low Date
2008-12-09
ATR
0.47
Beta
0.91
Ch YTD
-8.96
High
9.65
High52
13.83
High52 Date
2025-10-07
High52ch
-30.22%
Low
9.65
Low52
7.59
Low52 Date
2026-04-13
Low52ch
27.14%
Ma50ch
-3.24%
Price vs 200-day SMA
-11.1%
RSI
53.67
RSI Monthly
48.19
RSI Weekly
46.51
Sharpe ratio
0.49x
Sortino ratio
0.83
Total Return
-4.7%
Tr YTD
-8.96
Tr15y
495.67%
Tr1m
8.06%
Tr1w
8.79%
Tr3m
-10.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -8.6M
Operating margin
-14.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
17,077,994%
Net Borrowing
-26,626,032.9
Shares Insiders
3.26%
Shares Institutions
17.68%
Shares Qo Q
11.78%
Shares Yo Y
4.7%
Short Ratio
5.41

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Average Volume
1,560.45x
Bv Per Share
1.42
Ch10y
215.4
Ch15y
495.7
Ch1m
8.06
Ch1w
8.79
Ch1y
12.87
Ch20y
-79.92
Ch3m
-10.57
Ch3y
-12.11
Ch5y
32.19
Ch6m
-17.52
Change
-1.63%
Change From Open
0
Close
9.81
Days Gap
-1.63
Depreciation Amortization
140,350.9
Dollar Volume
974.7
Earnings Date
2026-05-14
EBIT
CAD -8.6M
EBITDA
CAD -8.5M
EPS
CAD -0.47
F Score
0
Financing CF
31,024,332
Fiscal Year End
December
Founded
1,996
Income Tax
CAD 145,339
Is Primary Listing
0
Last Earnings Date
2026-03-24
Last Report Date
2025-12-31
Last Split Date
2014-09-05
Last Split Type
Reverse
Ma150
11.13
Ma150ch
-13.29%
Ma20
8.94
Ma20ch
7.92%
Net CF
13,922,352
Next Earnings Date
2026-05-14
Open
9.65
Price Date
2026-05-08
Ptbv Ratio
6.77
Relative Volume
0.06x
Revenue
61,209,539x
SBC By Revenue
15.75x
Share Based Comp
9,643,087
Tax By Revenue
0.24x
Tr20y
-79.92%
Tr6m
-17.52%
Volume
101
Z Score
0.43
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/FRX pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/FRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+12.9%
S&P 500 1Y: n/a
3Y total return
-12.1%
S&P 500 3Y: n/a
5Y total return
+32.2%
S&P 500 5Y: n/a
10Y total return
+215.4%
S&P 500 10Y: n/a
Ownership

Who owns TSX/FRX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+17.7%
Share of float held by funds and institutions
Insider ownership
+3.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
5.4 days to cover
Y/Y dilution
+4.7%
Negative means the company is buying back shares.
Technical

TSX/FRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.7
Neutral momentum band
Price vs 200-day MA
-11.1%
50/200-day relationship not available
Beta (5Y)
0.91
Moves roughly with the market
Sharpe ratio
0.49
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/FRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/FRX stock rating?

tsx/FRX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/FRX analysis?

The full report lives at /stocks/tsx/FRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/FRX?

The latest report frames tsx/FRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/FRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.